GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Change In Other Working Capital

Remus Pharmaceuticals (NSE:REMUS) Change In Other Working Capital : ₹-313 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Change In Other Working Capital?

Remus Pharmaceuticals's Change In Other Working Capital for the quarter that ended in Sep. 2024 was ₹-637 Mil. It means Remus Pharmaceuticals's Other Working Capital declined by ₹637 Mil from Mar. 2024 to Sep. 2024 .

Remus Pharmaceuticals's Change In Other Working Capital for the fiscal year that ended in Mar. 2024 was ₹362 Mil. It means Remus Pharmaceuticals's Other Working Capital increased by ₹362 Mil from Mar. 2022 to Mar. 2024 .

Remus Pharmaceuticals Change In Other Working Capital Historical Data

The historical data trend for Remus Pharmaceuticals's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals Change In Other Working Capital Chart

Remus Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar24
Change In Other Working Capital
14.82 48.09 15.61 362.16

Remus Pharmaceuticals Semi-Annual Data
Mar20 Mar21 Mar22 Sep23 Mar24 Sep24
Change In Other Working Capital Get a 7-Day Free Trial - - 38.27 323.89 -636.97

Remus Pharmaceuticals Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-313 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Remus Pharmaceuticals Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Remus Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Change In Other Working Capital
Comparable Companies
NSE:DENTALKART BOM:544353 BOM:544143 BOM:536565 BOM:530697 BOM:543500 BOM:531240 BOM:523896 MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 SHSE:600332 XSWX:GALE MIL:AMP NZSE:EBO SHSE:600998
Traded in Other Exchanges
N/A
Address
Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054
Website
https://www.remuspharma.com
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines